Ligand Pharmaceuticals | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Amgen USD 6.21B 330M 2025-03
Arrowhead Research USD 52.59M 132.85M 2024-12
Baxter International USD 6.96B 908M 2024-12
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Ligand Pharmaceuticals USD 830.44M 10.74M 2024-12
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 48.34B 2.02B 2025-03
Pacira USD 778.35M 28.76M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Veracyte USD 1.18B 76K 2024-12



Ligand Pharmaceuticals Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.